P2RY1 and neoplasm: Furthermore, some tumor cells secrete soluble mediators like ADP [18], or thromboxane A2 (TXA2), which also affect the status of platelet activation by binding to platelet purinergic receptors P2Y12, P2Y1, and P2X1, or TXA2 receptor, respectively [19].